封面
市場調查報告書
商品編碼
1375885

預防性醫療保健技術和服務市場規模、佔有率和趨勢分析報告:2023-2030 年按類型、地區和細分市場分類的趨勢

Preventive Healthcare Technologies And Services Market Size, Share & Trends Analysis Report By Type (Early Detection & Screening, Chronic Disease Management, Vaccines), By Region, And Segment Forecasts, 2023 - 2030

出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

預防保健技術和服務市場成長和趨勢:

Grand View Research, Inc.最新報告顯示,到2030年,全球預防保健技術和服務市場規模預計將達到5,856億美元,2023年至2030年年複合成長率為11.8%。

推動市場擴張的關鍵因素是人們對預防措施的認知不斷增強,這些措施可以提高生活品質、延長壽命並最大限度地減少醫療支出。

該市場的成長得益於先進技術的採用以及疫苗、篩檢和監測設備以及智慧設備等預防措施的發展,以減少醫療錯誤。此外,出生率下降導致老年人口增加,老年人口更容易患慢性病,這也支持了市場成長。

自2010年以來,各國引入人類發展指數(HDI)評估,關注本國和人民的整體發展。預期壽命對 HDI 計算有重大影響。各國政府正在努力透過實施各種計劃來提高人口的預期壽命,包括免費或負擔得起的免疫接種、戒菸和負擔得起的健康保險。這些計劃對可預防的技術和服務領域產生直接的正面影響。

預防性醫療保健的很大一部分涉及早期檢測和篩檢技術。該領域與個體化診斷技術相關,並且由於診斷準確性和創新技術的可用性而獲得最大佔有率。

預防性醫療技術和服務市場報告亮點:

  • 根據世界衛生組織發布的資料,美國的疫苗接種比例正在上升。疫苗接種包括政府資助的疫苗和私人購買的疫苗。
  • 2022年,早期檢測和篩檢技術領域將佔據最大佔有率。個人化醫療技術的相關優勢,例如高精度和早期發現可能的疾病和失調,是該領域最大佔有率的主要驅動力。
  • 由於先進技術的引入和對準確篩檢方法的需求不斷成長,早期檢測和篩檢預計將在預測期內出現最快的成長。
  • 北美地區在 2022 年以 40.4% 的最大收益佔有率主導市場。
  • 經濟成長和政府配合措施預計將推動亞太地區的成長。預計該領域在預測期內複合年複合成長率將超過 14.2%。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 預防性醫療技術和服務市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 預防保健技術與服務市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 預防保健技術與服務市場:類型估計與趨勢分析

  • 預防保健技術與服務市場:重點
  • 預防性醫療技術和服務市場:2022 年和 2030 年趨勢和市場佔有率分析
  • 早期檢測與篩檢技術
  • 慢性病管理技術
  • 疫苗
  • 先進技術減少錯誤

第5章 預防性醫療技術與服務市場:區域估計與趨勢分析

  • 區域展望
  • 按地區分列的預防性醫療技術和服務市場:要點
  • 北美洲
    • 2018-2030 年北美市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 2018-2030 年歐洲市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 2018-2030 年亞太市場估計與預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市場估計與預測
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 2018 年至 2030 年 MEA 市場估計與預測
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Myriad Genetics, Inc.
    • Quest Diagnostics Incorporated
    • Medtronic
    • Abbott
    • Merck & Co., Inc.
    • GSK plc
    • Omnicell
    • MCKESSON CORPORATION
Product Code: GVR-1-68038-103-0

Preventive Healthcare Technologies And Services Market Growth & Trends:

The global preventive healthcare technologies and services market size is expected to reach USD 585.6 billion by 2030, registering a CAGR of 11.8% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Key factors driving the market expansion include the growing awareness about preventive measures, which enhance the quality of life, lifespan, and minimize the possible healthcare spending.

The growth of this market is attributed to the adoption of advanced technology and the development of preventive measures, including vaccines, screening & monitoring devices, and smart devices to reduce medical errors. Growth of the market is also fueled by factors such as reducing the birth rate that is resulting in an increase of the geriatric population, which is more prone to chronic diseases.

With the introduction of the Human Development Index (HDI) ratings since 2010, all countries are engaged in the overall development of their country and citizens. Life expectancy has a significant impact on HDI calculations. Governments of the countries have been focusing on improving life expectancy of the people by implementing various programs, including free or affordable vaccination, smoking cessation, and affordable insurance schemes. These programs cause a direct positive impact on preventable technologies and services space.

A large share of preventive healthcare includes early detection and screening technology. This segment pertains to personalized diagnostic techniques, which has captured the largest share owing to the accuracy and availability of the innovative techniques for diagnosis.

Preventive Healthcare Technologies And Services Market Report Highlights:

  • According to data published by the WHO, the percentage of the total vaccinations in the U.S. has been growing. The vaccinations included those funded by the government as well as private purchases.
  • In 2022, the early detection and screening technologies' segment captured the largest share. The advantages associated with personalized medicine technologies, such as high accuracy and detection of the possible disease or disorder at an early stage, are mainly attributed to the largest share of the segment.
  • With the introduction of advanced technology and the growing demand for accurate screening methods, the growth of early detection and screening is expected to be the fastest during the forecast period.
  • North America dominated the market with the largest revenue share of 40.4% in 2022.
  • Growing economies and government initiatives are expected to drive the growth of the Asia Pacific region. The segment is expected to witness a lucrative CAGR of over 14.2% during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Preventive Healthcare Technologies & Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Preventive Healthcare Technologies & Services Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Preventive Healthcare Technologies & Services Market: Type Estimates & Trend Analysis

  • 4.1. Preventive Healthcare Technologies & Services Market: Key Takeaways
  • 4.2. Preventive Healthcare Technologies & Services Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Early Detection & Screening Technologies
    • 4.3.1. Early detection & screening technologies market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.2. Automated screening
      • 4.3.2.1. Automated screening market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.3. Personalized medicine
      • 4.3.3.1. Personalized medicine market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.4. Other advanced screening technologies
      • 4.3.4.1. Other advanced screening technologies market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.4. Chronic Disease Management Technologies
    • 4.4.1. Chronic disease management technologies market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.2. Blood pressure monitors
      • 4.4.2.1. Blood pressure monitors market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.3. Asthma monitors
      • 4.4.3.1. Asthma monitors market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.4. Cardiovascular monitors
      • 4.4.4.1. Cardiovascular monitors market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.5. Glucose monitors
      • 4.4.5.1. Glucose monitors market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.5. Vaccines
    • 4.5.1. Vaccines market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.5.2. Infectious diseases
      • 4.5.2.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.5.3. Cancer vaccine
      • 4.5.3.1. Cancer vaccine market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.5.4. Autism vaccine
      • 4.5.4.1. Autism vaccine market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.5.5. Allergy vaccine
      • 4.5.5.1. Allergy vaccine market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.5.6. Other new vaccines
      • 4.5.6.1. Other new vaccines market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.6. Advanced Technologies to Reduce Errors
    • 4.6.1. Advanced technologies to reduce errors market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.6.2. Electronic prescribing
      • 4.6.2.1. Electronic prescribing market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.6.3. Clinical decision support system
      • 4.6.3.1. Clinical decision support system market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.6.4. Smart infusion pumps
      • 4.6.4.1. Smart infusion pumps market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.6.5. Computerized provider order entry system
      • 4.6.5.1. Computerized provider order entry system market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.6.6. Smart packaging
      • 4.6.6.1. Smart packaging market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Preventive Healthcare Technologies & Services Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Preventive Healthcare Technologies & Services Market by Region: Key Takeaway
  • 5.3. North America
    • 5.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. UK
      • 5.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. France
      • 5.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Norway
      • 5.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.9. Denmark
      • 5.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. Japan
      • 5.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. China
      • 5.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. India
      • 5.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Australia
      • 5.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.7. South Korea
      • 5.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Mexico
      • 5.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.4. Argentina
      • 5.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. South Africa
      • 5.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Myriad Genetics, Inc.
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Quest Diagnostics Incorporated
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Medtronic
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Abbott
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Merck & Co., Inc.
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. GSK plc
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Omnicell
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. MCKESSON CORPORATION
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 3 North America preventive healthcare technologies and services market, by region, 2018 - 2030 (USD Billion)
  • Table 4 U.S. preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 5 Canada preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 6 Europe preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 7 Europe preventive healthcare technologies and services market, by region, 2018 - 2030 (USD Billion)
  • Table 8 Germany preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 9 UK preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 10 France preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 11 Italy preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 12 Spain preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 13 Sweden preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 14 Norway preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 15 Denmark preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 16 Asia Pacific preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 17 Asia Pacific preventive healthcare technologies and services market, by region, 2018 - 2030 (USD Billion)
  • Table 18 China preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 19 Japan preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 20 India preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 21 Australia preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 22 Thailand preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 23 South Korea preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 24 Latin America preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 25 Latin America preventive healthcare technologies and services market, by region, 2018 - 2030 (USD Billion)
  • Table 26 Brazil preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 27 Mexico preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 28 Argentina preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 29 Middle East and Africa preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 30 Middle East and Africa preventive healthcare technologies and services market, by region, 2018 - 2030 (USD Billion)
  • Table 31 South Africa preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 32 Saudi Arabia preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 33 UAE preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 34 Kuwait preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Preventive healthcare technologies and services: market outlook
  • Fig. 9 Preventive healthcare technologies and services competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Preventive healthcare technologies and services market driver impact
  • Fig. 15 Preventive healthcare technologies and services market restraint impact
  • Fig. 16 Preventive healthcare technologies and services market strategic initiatives analysis
  • Fig. 17 Preventive healthcare technologies and services market: Type movement analysis
  • Fig. 18 Preventive healthcare technologies and services market: Type outlook and key takeaways
  • Fig. 19 Early detection & screening technologies market estimates and forecasts, (USD Billion) 2018 - 2030
  • Fig. 20 Automated screening market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 21 Personalized medicine market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 22 Other advanced screening technologies market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 23 Chronic disease management technologies market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 24 Blood pressure monitors market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 25 Asthma monitors market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 26 Cardiovascular monitors market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 27 Glucose monitors market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 28 Vaccines market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 29 Infectious diseases vaccine market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 30 Cancer vaccine market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 31 Autism vaccine market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 32 Allergy vaccine market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 33 Other new vaccines market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 34 Advanced technologies to reduce error market estimates and forecasts, (USD Billion) 2018 - 2030
  • Fig. 35 Electronic prescribing market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 36 Clinical decision supports system market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 37 Smart infusion pumps market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 38 Computerized provider order entry system market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 39 Smart packaging and automated prescription formulation and dispensing market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 40 Preventive healthcare technologies and services market: Regional movement analysis
  • Fig. 41 Preventive healthcare technologies and services market: Regional outlook and key takeaways
  • Fig. 42 North America market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 43 U.S. market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Canada market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 45 Europe market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 46 UK market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 47 Germany market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 48 France market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 49 Italy market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 50 Spain market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 51 Sweden market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 52 Norway market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 53 Denmark market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 55 Japan market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 56 China market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 57 India market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 58 Australia market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 59 Thailand market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 60 South Korea market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 61 Latin America market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 62 Brazil market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 63 Mexico market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 64 Argentina market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 65 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 66 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 67 South Africa market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 68 UAE market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 69 Kuwait market estimates and forecasts, 2018 - 2030 (USD Billion)